UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effects of Body Mass Index on the Lipid Profile and Biomarkers of Inflammation and a Fibrinolytic and Prothrombotic State

Journal of Atherosclerosis and Thrombosis, 2015/06/16, Vol.22(6), pp.610-617

2015

Volltextzugriff (PDF)

Chronic Kidney Disease and Third‐Generation P2Y12 Inhibitors Use in Patients With Acute Coronary Syndrome: Impact on the Prognosis at 1 Year

Journal of clinical pharmacology, 2019-02, Vol.59 (2), p.295-302

2019

Volltextzugriff (PDF)

Role of Platelets and Antiplatelet Therapy in Cardiovascular Disease

Journal of Atherosclerosis and Thrombosis, 2011, Vol.18(6), pp.431-442

2011

Volltextzugriff (PDF)

Impaired Responsiveness to the Platelet P2Y12 Receptor Antagonist Clopidogrel in Patients With Type 2 Diabetes and Coronary Artery Disease

Journal of the American College of Cardiology, 2014-09, Vol.64 (10), p.1005-1014

2014

Volltextzugriff (PDF)

Mini-STAR as bail-out strategy for percutaneous coronary intervention of chronic total occlusion

Catheterization and cardiovascular interventions, 2012-01, Vol.79 (1), p.30-40

2012

Volltextzugriff (PDF)

Antiplatelet therapy: thrombin receptor antagonists

British journal of clinical pharmacology, 2011-10, Vol.72 (4), p.658-671

2011

Volltextzugriff (PDF)

Antithrombotic Therapy in Patients with Peripheral Artery Disease: A Focused Review on Oral Anticoagulation

International journal of molecular sciences, 2021-07, Vol.22 (13), p.7113

2021

Volltextzugriff (PDF)

One‐year efficacy and safety of prasugrel and ticagrelor in patients with acute coronary syndromes: Results from a prospective and multicentre ACHILLES registry

British journal of clinical pharmacology, 2020-06, Vol.86 (6), p.1052-1061

2020

Volltextzugriff (PDF)

Impact of renal function on Ticagrelor-induced antiplatelet effects in coronary artery disease patients

International journal of cardiology. Heart & vasculature, 2023-06, Vol.46, p.101195-101195, Article 101195

2023

Volltextzugriff (PDF)

Chronic Kidney Disease and Third-Generation P2Y 12 Inhibitors Use in Patients With Acute Coronary Syndrome: Impact on the Prognosis at 1 Year

Journal of clinical pharmacology, 2019-02, Vol.59 (2), p.295-302

2019

Volltextzugriff (PDF)

Temporal Changes in Platelet Response in Acute Coronary Syndrome Patients With Prasugrel and Clopidogrel After Stent Implantation

Circulation Journal, 2018/01/25, Vol.82(2), pp.353-360

2018

Volltextzugriff (PDF)

Lone atrial fibrillation - a diagnosis of exclusion

Current pharmaceutical design, 2015-01, Vol.21 (5), p.544-550

2015

Volltextzugriff (PDF)

Pharmacodynamic effects of adjunctive cilostazol therapy in patients with coronary artery disease on dual antiplatelet therapy: Impact of high on-treatment platelet reactivity and diabetes mellitus status

Catheterization and cardiovascular interventions, 2013-01, Vol.81 (1), p.42-49

2013

Volltextzugriff (PDF)

Pharmacodynamic Effects of Cangrelor on Platelet P2Y12 Receptor–Mediated Signaling in Prasugrel-Treated Patients

JACC. Cardiovascular interventions, 2014-04, Vol.7 (4), p.426-434

2014

Volltextzugriff (PDF)

IMPACT OF PRASUGREL RELOAD DOSING REGIMENS ON HIGH ON–TREATMENT PLATELET REACTIVITY RATES IN PATIENTS ON MAINTENANCE PRASUGREL THERAPY

Journal of the American College of Cardiology, 2013-03, Vol.61 (10), p.E1920-E1920

2013

Volltextzugriff (PDF)

The Effect of Low-Dose Ticagrelor on Platelet Function Profiles in Patients With Stable Coronary Artery Disease in Trinidad: The TWIST Pilot Study

Cardiology and therapy, 2020-12, Vol.9 (2), p.493-503

2020

Volltextzugriff (PDF)

TRimetazidine as an Agent to affeCt clopidogrEl Response: The TRACER Study

Cardiology and therapy, 2019-12, Vol.8 (2), p.229-237

2019

Volltextzugriff (PDF)

Prasugrel for the treatment of coronary thrombosis: a review of pharmacological properties, indications for use and future development

Expert opinion on investigational drugs, 2011-01, Vol.20 (1), p.119-133

2011

Volltextzugriff (PDF)

PHARMACODYNAMIC EFFECTS OF EV–077 IN PATIENTS WITH DIABETES MELLITUS ON CLOPIDOGREL MONOTHERAPY: RESULTS OF AN IN VITRO PILOT INVESTIGATION

Journal of the American College of Cardiology, 2013-03, Vol.61 (10), p.E1830-E1830

2013

Volltextzugriff (PDF)

Impact of Prasugrel Reload Dosing Regimens on High On-Treatment Platelet Reactivity Rates in Patients on Maintenance Prasugrel Therapy

JACC. Cardiovascular interventions, 2013-02, Vol.6 (2), p.182-184

2013

Volltextzugriff (PDF)

Primary Prevention With Aspirin in Type 2 Diabetic Patients: Searching for the Right Spot

Circulation Journal, 2012, Vol.76(6), pp.1333-1334

2012

Volltextzugriff (PDF)

Management of atrial fibrillation

Heart (British Cardiac Society), 2006-08, Vol.92 (8), p.1177-1182

2006

Volltextzugriff (PDF)

Antiplatelet drug therapy: role of pharmacodynamic and genetic testing

Future cardiology, 2011-05, Vol.7 (3), p.381-402

2011

Volltextzugriff (PDF)

Respuesta al ECG de julio de 2015

Revista española de cardiologia, 2015-08, Vol.68 (8), p.718-718

Tello-Montoliu, Antonio

2015

Volltextzugriff (PDF)

1 – 25 von 129

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(111)
Mit Volltextzugriff
(111)

Publikationsform

Artikel
(128)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(70)
Science & Technology
(70)
Humans
(60)
Cardiovascular System & Cardiology
(58)
Cardiac & Cardiovascular Systems
(50)
Male
(38)
Female
(37)
Aged
(31)
Middle Aged
(30)
Cardiovascular
(24)
Prospective Studies
(24)
Cardiology
(22)
Internal Medicine
(20)
Ticlopidine - Analogs & Derivatives
(18)
Clopidogrel
(17)
Coronary Artery Disease - Drug Therapy
(17)
Peripheral Vascular Disease
(16)
Treatment Outcome
(16)
Acute Coronary Syndrome
(15)
Blood Platelets - Drug Effects
(15)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Effects of Body Mass Index on the Lipid Profile and Biomarkers of Inflammation and a Fibrinolytic and Prothrombotic State

Chronic Kidney Disease and Third‐Generation P2Y12 Inhibitors Use in Patients With Acute Coronary Syndrome: Impact on the Prognosis at 1 Year

Role of Platelets and Antiplatelet Therapy in Cardiovascular Disease

Impaired Responsiveness to the Platelet P2Y12 Receptor Antagonist Clopidogrel in Patients With Type 2 Diabetes and Coronary Artery Disease

Mini-STAR as bail-out strategy for percutaneous coronary intervention of chronic total occlusion

Antiplatelet therapy: thrombin receptor antagonists

Antithrombotic Therapy in Patients with Peripheral Artery Disease: A Focused Review on Oral Anticoagulation

One‐year efficacy and safety of prasugrel and ticagrelor in patients with acute coronary syndromes: Results from a prospective and multicentre ACHILLES registry

Impact of renal function on Ticagrelor-induced antiplatelet effects in coronary artery disease patients

Chronic Kidney Disease and Third-Generation P2Y 12 Inhibitors Use in Patients With Acute Coronary Syndrome: Impact on the Prognosis at 1 Year

Temporal Changes in Platelet Response in Acute Coronary Syndrome Patients With Prasugrel and Clopidogrel After Stent Implantation

Lone atrial fibrillation - a diagnosis of exclusion

Pharmacodynamic effects of adjunctive cilostazol therapy in patients with coronary artery disease on dual antiplatelet therapy: Impact of high on-treatment platelet reactivity and diabetes mellitus status

Disparities in the Estimation of Glomerular Filtration Rate According to Cockcroft‐Gault, Modification of Diet in Renal Disease‐4, and Chronic Kidney Disease Epidemiology Collaboration Equations and Relation With Outcomes in Patients With Acute Coronary Syndrome

Pharmacodynamic Effects of Cangrelor on Platelet P2Y12 Receptor–Mediated Signaling in Prasugrel-Treated Patients

IMPACT OF PRASUGREL RELOAD DOSING REGIMENS ON HIGH ON–TREATMENT PLATELET REACTIVITY RATES IN PATIENTS ON MAINTENANCE PRASUGREL THERAPY

The Effect of Low-Dose Ticagrelor on Platelet Function Profiles in Patients With Stable Coronary Artery Disease in Trinidad: The TWIST Pilot Study

TRimetazidine as an Agent to affeCt clopidogrEl Response: The TRACER Study

Prasugrel for the treatment of coronary thrombosis: a review of pharmacological properties, indications for use and future development

PHARMACODYNAMIC EFFECTS OF EV–077 IN PATIENTS WITH DIABETES MELLITUS ON CLOPIDOGREL MONOTHERAPY: RESULTS OF AN IN VITRO PILOT INVESTIGATION

Impact of Prasugrel Reload Dosing Regimens on High On-Treatment Platelet Reactivity Rates in Patients on Maintenance Prasugrel Therapy

Primary Prevention With Aspirin in Type 2 Diabetic Patients: Searching for the Right Spot

Management of atrial fibrillation

Antiplatelet drug therapy: role of pharmacodynamic and genetic testing

Respuesta al ECG de julio de 2015

Suchergebnisse filtern